Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,187 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06638424Recruiting
Cataract surgery effects on eyes in diabetic patients
This study looks at how cataract surgery affects the surface of the eye in people with diabetes. Researchers want to see if the surgery causes changes, so they can better understand and care for diabetic patients.
StrasbourgAges 18 years+ - NCT06639763Recruiting
Erectile aid use after gender-affirming surgery
This study looks at how transgender men and their partners use erectile aids after phalloplasty or metoidioplasty. It hopes to improve sexual health and satisfaction after surgery.
Ghent, East-FlandersAges 18 years+ - NCT07710690RecruitingPhase 1
Study of NRG-103 injection for recurrent high-grade glioma
This trial tests a new injection called NRG-103 for people whose high-grade glioma (a fast-growing brain tumor) has come back after standard treatments. The goal is to see if it's safe and if it might help shrink the tumor.
ShanghaiAges 18 years+ - NCT07711262RecruitingPhase 3
Study of Rupatifen for seasonal allergic rhinitis
This trial tests an experimental capsule called Rupatifen for adults with seasonal allergies. It aims to see if it reduces symptoms like sneezing, runny nose, and congestion during spring or fall allergy seasons.
Baoding, HebeiAges 18–65 - NCT07711184RecruitingPhase 1
Testing an oral drug for advanced prostate cancer
This study tests a new oral tablet (HRS-7525) for men with advanced prostate cancer that has spread. It aims to see if the drug is safe and effective, and may offer a new treatment option for those who have not responded to standard therapies.
Sydney, New South WalesAges 18–80 - NCT07712913RecruitingPhase 3
Pregabalin for nerve pain from diabetes or shingles
This trial tests an extended-release version of pregabalin (a pain medication) for people with long-term nerve pain caused by diabetes or shingles. It aims to see if this once-daily pill can reduce pain with fewer side effects.
Salvador, Estado de BahiaAges 18–75 - NCT07713732RecruitingPhase 1
Combination treatment for advanced solid tumors
This trial tests a new drug called TLN-499 combined with another drug (venetoclax) for people with certain advanced solid tumors that have not responded well to previous treatments. The goal is to see if the combination is safe and might help shrink tumors.
Camperdown, New South WalesAges 18 years+ - NCT07710248RecruitingPhase 2
Safety of SG301-SC in adults with ITP
This study tests a new injection called SG301-SC for people with primary immune thrombocytopenia (ITP) whose platelet counts stay low even after standard treatments. The goal is to see if it is safe and helps raise platelets, reducing bleeding risk.
Fuzhou, FujianAges 18–75 - NCT07711418RecruitingPhase 3
A study of rezpegaldesleukin for teenagers and adults with moderate-to-severe eczema
This trial tests an investigational drug called rezpegaldesleukin for people aged 12 and older with moderate-to-severe atopic dermatitis (eczema) that hasn't improved enough with topical treatments. The goal is to see if it can safely reduce eczema symptoms.
Birmingham, AlabamaAges 12 years+ - NCT07710885RecruitingPhase 3
Futibatinib for advanced bile duct cancer
This trial tests a new targeted therapy, futibatinib, for people with advanced or unresectable bile duct cancer who have not had prior treatment for advanced disease. It aims to see if this drug can help shrink or control the cancer.
BrisbaneAges 18 years+ - NCT07714330Recruiting
Using sound cues to treat positional sleep apnea
This study tests a device that plays sound cues to help you stay off your back while sleeping, which may reduce sleep apnea events. It's for people whose sleep apnea is worse when sleeping on their back.
Burlingame, CaliforniaAges 18–75 - NCT07708142RecruitingPhase 3
Testing a new injection for swelling after retinal vein blockage
This trial tests a new medicine called SMO1 for people with vision loss and swelling in the eye caused by a blocked vein in the retina. It involves regular eye injections to see if the medicine can reduce swelling and improve vision.
Seoul, Gangdong-guAges 19 years+ - NCT07709520RecruitingPhase 2
Testing a new hepatitis B treatment in adults
This trial tests a new treatment (GST-HG131&141 tablets) versus a placebo for people with chronic hepatitis B. It aims to see if the treatment can better control the virus in those already on stable therapy.
BeijingAges 35–65 - NCT07708116RecruitingPhase 1
First human trial of CTX-187 for healthy people and those with chronic infection
This trial tests a new drug called CTX-187 in two groups: healthy volunteers (Parts A and B) and people with chronic lung infection from bronchiectasis (Part C). It helps find the right dose and checks safety.
GroningenAges 18–65 - NCT06640660Recruiting
Study of vision, thinking, and emotions in MS and West Nile
This study looks at how multiple sclerosis or West Nile virus affects visual thinking and mood, and whether a rehab program might help. If you have one of these conditions and can see and use your hands, you may be able to join.
Lido, VeneziaAges 20–85 - NCT06642623RecruitingPhase 4
Study on heart and kidney health in type 2 diabetes
This trial tests enavogliflozin (a newer SGLT2 inhibitor) compared to older drugs (dapagliflozin or empagliflozin) to see how well it protects the heart and kidneys in people with type 2 diabetes.
SeoulAges 19 years+ - NCT07709208Recruiting
Mitral valve repair for leak that worsens with exercise
This trial tests a procedure to fix a leaky mitral valve that only becomes severe during exercise. It may help people with symptoms like shortness of breath or fatigue who haven't responded to standard heart medications.
DüsseldorfAges 18 years+ - NCT07708571Recruiting
Coaching program for women on ribociclib and aromatase inhibitor
This study tests whether a coaching program based on personality types helps women with early-stage hormone receptor-positive, HER2-negative breast cancer stick to their treatment plan. Participants must be taking ribociclib (Kisqali) and an aromatase inhibitor, and their cancer must not have spread to other organs.
Augsburg, BavariaAges 18 years+ - NCT07707115Recruiting
Simulation training for resilience and empathy in birth care
This trial tests a simulation program to improve resilience and empathy among healthcare workers who interact with birthing individuals at the University of Utah Hospital. It may help you better cope with stress and connect with patients.
Salt Lake City, UtahAges 18 years+ - NCT07708740Recruiting
Two doses of ketamine for preventing slow heart rate during eye surgery
This study tests whether two doses of ketamine (a medicine given through a vein) can reduce a reflex that slows the heart during eye surgery. If you are having eye surgery that involves moving the eye muscles, you may be eligible.
CairoAges 18–65 - NCT07707258Recruiting
Remimazolam with oliceridine for sedation in older adults during GI endoscopy
This trial tests two medicines, remimazolam (a sedative) and oliceridine (a pain reliever), to see if they work well together for sedation during a painless gastrointestinal (GI) endoscopy in people aged 65 to 80. It aims to find a safe and effective option for older adults.
Shanghai, Shanghai MunicipalityAges 65–80 - NCT07713121Recruiting
Keeping blood pressure up during surgery to prevent confusion in older adults
This trial tests whether keeping blood pressure at 85 mmHg or higher during surgery can reduce confusion (delirium) after surgery. It is for older adults with high blood pressure who are having non-cardiac surgery.
HamburgAges 65 years+ - NCT07713537Recruiting
Stroke risk score for AF patients on blood thinners
This study is testing a new scoring system to predict stroke risk in people with atrial fibrillation who are taking DOAC blood thinners. The goal is to help doctors personalize treatment and prevent blood clots.
Barcelona, BarcelonaAges Any age - NCT07714278Enrolling by invitation
Video-based rehab for chemotherapy nerve damage
This study tests a personalized rehab program using video analysis to help people with chemotherapy-induced nerve damage (numbness, tingling, weakness) improve their walking and daily life.
Seongnam-si, Gyeonggi-doAges 19 years+
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,187 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.